GSK

U.S. attorneys representing a woman who alleges her colon cancer stems from the now-discontinued heartburn drug Zantac told a Chicago jury on Thursday that pharmaceutical giants GSK and Boehringer Ingelheim were aware that improper handling of the product could lead to cancer but failed to issue warnings to the public. Mikal Watts, representing 89-year-old Angela…